|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 Massachusetts Avenue, NW |
Address2 | Suite 610 |
City | Washington |
State | DC |
Zip Code | 20001-1430 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Rolling Meadows |
State | IL |
Zip Code | 60008 |
Country | USA |
|
5. Senate ID# 1648-12
|
||||||||
|
6. House ID# 338710000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: KATHERINE O. ORRICO |
Date | 7/19/2019 4:01:31 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 348, Resident Physician Shortage Reduction Act, to provide Medicare funding for additional residency training slots
S. 966, Medicare Care Coordination Improvement Act, to modernize the physician self-referral prohibitions to promote care coordination in the merit-based incentive payment system and to facilitate physician practice participation in alternative payment models under the Medicare program
H.R. 1763, Resident Physician Shortage Reduction Act, to provide Medicare funding for additional residency training slots
H.R. 2282, Medicare Care Coordination Improvement Act, to modernize the physician self-referral prohibitions to promote care coordination in the merit-based incentive payment system and to facilitate physician practice participation in alternative payment models under the Medicare program
H.R.3030, Patient-Centered Outcomes Research Extension Act, to amend the Internal Revenue Code of 1986 and title XI of the Social Security Act to extend appropriations and transfers to the Patient-Centered Outcomes Research Trust Fund and to extend certain health insurance fees for such transfers
H.R.3107, Improving Seniors Timely Access to Care Act, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans, and for other purposes
H.R. 3302, Keep Physicians Serving Patients ActTo improve the accuracy of geographic adjustment factors under the Medicare program and to permanently extend certain adjustments to such factors for certain localities
No bill: Repealing/modifying Medicare's Appropriate Use Criteria Program for Advance Diagnostic Imaging
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 350, Competitive Health Insurance Reform Act, to restore the application of the Federal antitrust laws to the business of health insurance
S.864, Ellies Law, to provide for further comprehensive research at the National Institute of Neurological Disorders and Stroke on unruptured intracranial aneurysms
S.1350, Good Samaritan Health Professionals Act, A bill to amend the Public Health Service Act to limit the liability of health care professionals who volunteer to provide health care services in response to a disaster
S. 1379, Pandemic and All-Hazards Preparedness and Advancing Innovation Act, to reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application.
S.1531, STOP Surprise Medical Bills Act, To amend the Public Health Service Act to provide protections for health insurance consumers from surprise billing
S, 1895, Lower Health Care Costs Act, to lower health care costs
S. 2010, Cerebral Cavernous Malformations Clinical Awareness, Research, and Education (CCM-CARE) Act, to increase research, education, and treatment for cerebral cavernous malformations
S.Res.245, A resolution designating July 17, 2019, as "Glioblastoma Awareness Day
H.R. 280, Concussion Awareness and Education Act, to provide for systemic research, treatment, prevention, awareness, and dissemination of information with respect to sports-related and other concussions
H.R.594, Ellies Law, to provide for further comprehensive research at the National Institute of Neurological Disorders and Stroke on unruptured intracranial aneurysms
H.R. 1418, Competitive Health Insurance Reform Act, to restore the application of the Federal antitrust laws to the business of health insurance
HR. 1554, Resident Education Deferred Interest Act, to provide for interest-free deferment on student loans for borrowers serving in a medical residency program.
H.R.2279, Safe Step Act, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol
H.R.3502, Protecting People from Surprise Medical Bills Act, To protect health care consumers from surprise billing practices
H.R.3573, Cerebral Cavernous Malformations Clinical Awareness, Research, and Education (CCM-CARE) Act, to increase research, education, and treatment for cerebral cavernous malformations
H.R.3630, No Surprises Act, To protect health care consumers from surprise billing practices, and for other purposes;
H.Res.366, Expressing support for designation of May as Stroke Awareness Month
No Bill: Comprehensive medical liability reform and reintroduction of the Accessible Care by Curbing Excessive lawSuitS (ACCESS) Act
No Bill: Reintroduction of the Good Samaritan Health Professionals Act, to amend the Public Health Service Act to limit the liability of health care professionals who volunteer to provide health care services in response to a disaster
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
S. 692, Protect Medical Innovation Act, to repeal the excise tax on medical devices
H.R. 2207, the Protect Medical Innovation Act of 2019, to amend the Internal Revenue Code of 1986 to repeal the excise tax on medical devices
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S. 864, Ellie's Law, to provide additional funding for comprehensive research at the National Institute of Neurological Disorders and Stroke on unruptured intracranial aneurysms
H.R. 594, Ellie's Law, to provide additional funding for comprehensive research at the National Institute of Neurological Disorders and Stroke on unruptured intracranial aneurysms
FY 2020 Labor, HHS, Education Appropriations, Provides FY 2020 funding to the Department of Health & Human Services.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |